Keren Rouvinov

8PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsLiquid biopsiesSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

|May 27, 2026
Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

|Apr 24, 2026
Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

|Mar 28, 2026
Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer.

Keren Rouvinov, Rashad Naamneh, Alexander Yakobson

|Feb 27, 2026
The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology.

Keren Rouvinov, Rashad Naamneh, Alexander Yakobson

|Sep 22, 2025
Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases.

Walid Shalata, Rashad Naamneh, Wenad Najjar

Pageof 2

Frequent Collaborators

7 joint publications

Walid Shalata

3 joint publications

Rashad Naamneh

3 joint publications

Wenad Najjar

3 joint publications

Mahmoud Abu Amna